Skip to main content

Animations

MJFF Publications

2841 - 2850 of 8471 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    RESTRICTED
    Title: Disease modifying therapies for Parkinson's disease: Novel targets
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108839
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2021.100455
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Large‐scale deep multi‐layer analysis of Alzheimer’s disease brain reveals strong proteomic disease‐related changes not observed at the RNA level
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.055041
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: LRRK2 signaling in neurodegeneration: two decades of progress
    Journal Name: Essays in Biochemistry
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1042/ebc20210013
    Best OA location URL:
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Neuropathological evidence of body-first vs. brain-first Lewy body disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105557
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Programmed autophagy prevents excess organelle baggage during neurogenesis
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.034
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Progression of Self-Perceived Speech and Swallowing Impairment in Early Stage Parkinson's Disease: Longitudinal Analysis of the Unified Parkinson's Disease Rating Scale
    Journal Name: Journal of Speech, Language, and Hearing Research
    Publisher: American Speech Language Hearing Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1044/2021_jslhr-21-00216
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tau
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.050391
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics
    Journal Name: ISME Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43705-021-00078-0
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jev2.12182
    Citation Count: 263
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.